Prognostic significance of pre-treatment albumin-bilirubin grade in metastatic urothelial carcinoma receiving pembrolizumab.

Shimpei YamashitaTakuma WadaRyusuke DeguchiNobuyuki MashimaMasatoshi HiguchiHaruka MiyaiHiroyuki KoikeYasuo KohjimotoIsao Hara

Published in: Japanese journal of clinical oncology (2023)

High pre-treatment albumin-bilirubin grade could be a significant independent predictor of poor prognosis in patients receiving pembrolizumab for advanced urothelial carcinoma.

Keyphrases

poor prognosis
long non coding rna
squamous cell carcinoma
small cell lung cancer
replacement therapy